NewcelX Ltd. (NCEL)

NASDAQ: NCEL · Real-Time Price · USD
7.29
0.00 (0.00%)
At close: Oct 31, 2025, 4:00 PM
6.91
-0.38 (-5.21%)
After-hours: Oct 31, 2025, 7:31 PM EDT
Market Cap32.88M
Revenue (ttm)n/a
Net Income (ttm)-18.49M
Shares Out 4.51M
EPS (ttm)-4.32
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,247,026
Open5.26
Previous Closen/a
Day's Range4.20 - 7.45
52-Week Range4.20 - 47.40
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateDec 1, 2025

About NCEL

NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquartered in Zurich, Switzerland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 15
Stock Exchange NASDAQ
Ticker Symbol NCEL
Full Company Profile

Financial Performance

Financial numbers in ILS Financial Statements

News

There is no news available yet.